MedPath

Pivotal Clinical Study to Assess the Anti-adhesive Effect and Safety of ABT13107 Applied to Postoperative Intrauterine

Not Applicable
Completed
Conditions
Postoperative Adhesion of Uterus
Registration Number
NCT04007211
Lead Sponsor
Medy-Tox
Brief Summary

This study is intended to evaluate the efficacy and safety of ABT13107 compared to Hyalobarrier applied to postoperative intrauterine.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
192
Inclusion Criteria
  • Female patients aged from 19 to 70
  • Those who are scheduled for hysteroscopy to treat the following diseases: submucosal myomas, endometrial polyps, intrauterine adhesion etc.
Exclusion Criteria
  • Those who will apply other intrauterine device rather than investigational device during the study period.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Incidence of intrauterine adhesion4 weeks

Incidence rate of intrauterine adhesion after surgery

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Asan Medical Center

🇰🇷

Seoul, Korea, Republic of

Asan Medical Center
🇰🇷Seoul, Korea, Republic of

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.